The Chinese government recently released new regulatory measures for clinical trials at medical institutions. The document lays out a strengthened code of conduct for hospitals and doctors conducting clinical trials. Companies that are carrying out clinical trials at Chinese hospitals should ensure that their policies and processes comply with the new laws.
On December 19, 2014, China Food and Drug Administration (CFDA) issued the Administrative Measures for Food and Drug Supervision Statistics (CFDA Order No. 10). The Administrative Measures was adopted at the executive meeting of CFDA on September 29, 2014 and will come into force as of February 1, 2015.